Hematologic Malignancy
Myelodysplastic Chronic Myelomonocytic Leukemia
CI-CAN-00006069Explore in graph →
Hematologic1 active trials
- NCIt
- C203443
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00006069Explore in graph →
Clinical trials
1 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (0)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07582172 | Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome | recruiting | Phase 2 | 35 | City of Hope Medical CenterOTHER | 1 | Aug 20, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Aug 20, 2026source: clinicaltrials